Locations
San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2012
Pendulum Therapeutics is a pioneering company in the probiotics market, leveraging evidence-based microbiome science to develop innovative therapies. Their flagship product, Pendulum Glucose Control, is a medical probiotic clinically shown to improve A1C levels in type 2 diabetes patients. Founded by a team of PhD scientists from prestigious institutions, Pendulum differentiates itself through proprietary strains, rigorous research, and partnerships with leading medical organizations like the Mayo Clinic. With a strong focus on clinical efficacy and cutting-edge manufacturing processes, Pendulum is positioned as a leader in the microbiome health space, aiming to transform gut health and metabolic function for consumers.
Something looks off?On-site & Remote